Ministry of Education
Vidvan Image

Dr Rahul Shukla

vidwan id: 462758
Male

Senior Scientist, Department of Molecular Microbiology and Immunology
Central Drug Research Institute

Orchid Icon 0000-0002-4320-9512 Google Scholar Icon 57189708616

Publications

Total Articles 20
Books 0
Proceedings 0

Publications

No publication activity to display at the moment.

Scopus

Citations 348
h-index 10

CrossRef

CrossRef Icon
Citations 20
h-index 1
Google Scholar

Loading Scholar statistics...

Professional Recognition

No Data Found

There is currently nothing to display here.

Community & Membership

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Bio

Dr. Shukla have over 12 years of experience in Viral immunology and developing the antiviral strategies. During his Ph.D. he had designed a recombinant dengue vaccine candidate and established an in-house mouse model (first time in India) to assess the antibody-mediated disease enhancement of dengue vaccine candidates. Later, he transferred this “know-how” to Sun Pharmaceutical Pvt. Ltd. Besides this, he was actively engaged in the anti-dengue botanical drug development program of ICGEB-Sun Phar

Personal Details

  • Male
  • Senior Scientist , Central Drug Research Institute
  • CSIR-Central Drug Research Institute
Ph.D
Other Institute 2017
Senior Scientist Jun 2021 – Present
Central Drug Research Institute | Department of Molecular Microbiology and Immunology

Related Profiles

Experts (0)

no data found

Organisations (93+)

View All
Bhupendra N

Dr Bhupendra N Singh

Chief Scientist

Baisakhi

Dr Baisakhi Moharana

Senior Scientist

Atul

Prof Atul Goel

Chief Scientist

Arun Kumar

Dr Arun Kumar Trivedi

Senior Principal Scientist

Ashish

Dr Ashish Awasthi

Senior Scientist

Ashish

Dr Ashish Arora

Senior Scientist

Asif

Dr Asif Ali

Principal Scientist

Bidyut

Dr Bidyut Purkait

Senior Scientist

Aamir

Dr Aamir Nazir

Senior Principal Scientist

Amogh Anant

Dr Amogh Anant Sahasrabuddhe

Senior Principal Scientist

Co-Authors (4)

Prasoon Kumar

Dr Prasoon Kumar Gupta

Indian Institute of Integrative Medicine

S K

Mr S K Jain

Jamia Hamdard

Sumeet

Dr Sumeet Gairola

Hemwati Nandan Bahuguna Garhwal University

Sumeet

Dr Sumeet Gairola

Indian Institute of Integrative Medicine

Scholarly Work

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Scholarly Publications

Cocculus hirsutus-derived phytopharmaceutical drug has potent anti-dengue activity

Open Access
other
Year: 2020.
Authors:
DOI 10.1101/2020.09.18.303149

Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models

Open Access
Article
EBioMedicine. Year: 2020. Volume: 60 .
Authors: Shukla R.;Beesetti H.;Brown J.A.;Ahuja R.;Ramasamy V.;Shanmugam R.K.;Poddar A.;Batra G.;Krammer F.;Lim J.K.;Kale S.;Lal A.A.;Swaminathan S.;Khanna N.
DOI 10.1016/j.ebiom.2020.102991
20

Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine

Open Access
Review
Frontiers in Cellular and Infection Microbiology. Year: 2020. Volume: 10 .
Authors: Shukla R.;Ramasamy V.;Shanmugam R.K.;Ahuja R.;Khanna N.
DOI 10.3389/fcimb.2020.572681
100

Pichia pastoris-expressed Zika virus envelope domain III on a virus-like particle platform: Design, production and immunological evaluation

Open Access
Conference Paper
Pathogens and Disease. Year: 2019. Volume: 77 , Issue: 3 .
Authors: Shanmugam R.K.;Ramasamy V.;Shukla R.;Arora U.;Swaminathan S.;Khanna N.
DOI 10.1093/femspd/ftz026
17

Next generation designer virus-like particle vaccines for dengue

Open Access
Review
Expert Review of Vaccines. Year: 2019. Volume: 18 , Issue: 2 , Pages: 105-117 .
Authors: Shukla R.;Ramasamy V.;Rajpoot R.;Arora U.;Poddar A.;Ahuja R.;Beesetti H.;Swaminathan S.;Khanna N.
DOI 10.1080/14760584.2019.1562909
7

Dengue envelope-based 'four-in-one' virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice.

Open Access
journal-article
Scientific Reports. Year: 2018.
Authors:

A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice

Open Access
Article
PLOS Neglected Tropical Diseases. Year: 2018. Volume: 12 , Issue: 1 .
Authors: Ramasamy V.;Arora U.;Shukla R.;Poddar A.;Shanmugam R.K.;White L.J.;Mattocks M.M.;Raut R.;Perween A.;Tyagi P.;de Silva A.M.;Bhaumik S.K.;Kaja M.K.;Villinger F.;Ahmed R.;Johnston R.E.;Swaminathan S.;Khanna N.
DOI 10.1371/journal.pntd.0006191
62

Pichia pastoris-expressed bivalent virus-like particulate vaccine induces domain III-focused bivalent neutralizing antibodies without antibody-dependent enhancement in vivo

Open Access
Article
Frontiers in Microbiology. Year: 2018. Volume: 8 , Issue: JAN .
Authors: Shukla R.;Rajpoot R.;Arora U.;Poddar A.;Swaminathan S.;Khanna N.
DOI 10.3389/fmicb.2017.02644
27